1. Home
  2. CRVS vs TG Comparison

CRVS vs TG Comparison

Compare CRVS & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • TG
  • Stock Information
  • Founded
  • CRVS 2014
  • TG 1988
  • Country
  • CRVS United States
  • TG United States
  • Employees
  • CRVS N/A
  • TG N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • TG Metal Fabrications
  • Sector
  • CRVS Health Care
  • TG Industrials
  • Exchange
  • CRVS Nasdaq
  • TG Nasdaq
  • Market Cap
  • CRVS 305.4M
  • TG 301.0M
  • IPO Year
  • CRVS 2016
  • TG 1989
  • Fundamental
  • Price
  • CRVS $5.75
  • TG $7.84
  • Analyst Decision
  • CRVS Strong Buy
  • TG
  • Analyst Count
  • CRVS 4
  • TG 0
  • Target Price
  • CRVS $15.00
  • TG N/A
  • AVG Volume (30 Days)
  • CRVS 518.7K
  • TG 89.4K
  • Earning Date
  • CRVS 08-07-2025
  • TG 08-08-2025
  • Dividend Yield
  • CRVS N/A
  • TG N/A
  • EPS Growth
  • CRVS N/A
  • TG N/A
  • EPS
  • CRVS N/A
  • TG N/A
  • Revenue
  • CRVS N/A
  • TG $643,014,000.00
  • Revenue This Year
  • CRVS N/A
  • TG N/A
  • Revenue Next Year
  • CRVS N/A
  • TG N/A
  • P/E Ratio
  • CRVS N/A
  • TG N/A
  • Revenue Growth
  • CRVS N/A
  • TG 28.10
  • 52 Week Low
  • CRVS $2.54
  • TG $5.86
  • 52 Week High
  • CRVS $10.00
  • TG $9.43
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 65.10
  • TG 46.37
  • Support Level
  • CRVS $5.28
  • TG $7.68
  • Resistance Level
  • CRVS $5.64
  • TG $8.03
  • Average True Range (ATR)
  • CRVS 0.30
  • TG 0.20
  • MACD
  • CRVS 0.03
  • TG 0.06
  • Stochastic Oscillator
  • CRVS 77.70
  • TG 75.00

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

Share on Social Networks: